ATS Medical, Inc. announced the first implant and FDA clearance of the ATS Simulus Semi-Rigid Annuloplasty Band. ATS Simulus Semi-Rigid Annuloplasty Band was developed in collaboration with Genesee BioMedical products.
In the cases where repair of a patient’s heart valve is preferred to replacement of the valve, the Annuloplasty rings and bands provides better options. The ATS Simulus Semi-Rigid Annuloplasty Band expands the existing therapeutic options for surgeons and their patients. The Simulus Semi-Rigid Band is specifically designed to respect the natural motion of the mitral annulus during the cardiac cycle allowing for a more physiologic valve repair.
Dr. Robert F. Hebeler, Jr., who performed the first implant of the ATS Simulus Semi-Rigid Band at Heart Hospital Baylor in Plano, Texas commented, This Simulus Semi-Rigid Band represents the next advancement in annuloplasty repair rings and provides an excellent option for my patients with mitral valve regurgitation. The band retains the natural saddle shape of the mitral valve annulus and preserves mobility during the cardiac phases, particularly in the aorto-mitral junction. These design characteristics make the Simulus Semi-Rigid Band easy to implant.
Michael Dale, President and CEO of ATS Medical added, We are excited about the growth and innovation we have brought to the annuloplasty repair market. Our portfolio of Simulus annuloplasty products continues to be an important contribution to our heart valve therapy product platform.